COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice

This review highlights advancements in COVID-19 mRNA vaccine technology and discusses challenges posed by variant-driven immune escape.

The COVID-19 pandemic has established mRNA vaccines as a validated platform for rapid vaccine development.

No numerical data presented in the source material.

First-generation mRNA vaccines demonstrated strong protection against severe disease but faced challenges with waning immunity and variant escape.
Protection against hospitalization and death remained durable, especially after booster doses targeting newer variants.
Technological innovations are being developed to improve vaccine durability and immune response.
Immunocompromised individuals, pregnant women, and older adults may require tailored vaccination strategies.
mRNA technology is expanding into other areas, including respiratory virus vaccines and cancer immunotherapy.

Healthcare professionals should monitor the evolving landscape of mRNA vaccine technology.

Ongoing research and innovation will be critical in shaping future vaccination strategies.

Clinical Report: Future Perspectives on COVID-19 mRNA Vaccines